Bromodomains: Structure, function and pharmacology of inhibition

被引：168

作者：

Ferri, Elena ^{[1
]}

Petosa, Carlo ^{[2
,3
,4
]}

McKenna, Charles E. ^{[1
]}

机构：

[1] Univ So Calif, Dept Chem, Dana & David Dornsife Coll Letters Arts & Sci, Univ Pk Campus, Los Angeles, CA 90089 USA

[2] Univ Grenoble Alpes, Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France

[3] CNRS, IBS, F-38044 Grenoble, France

[4] Commissariat Energie Atom & Energies Alternat, IBS, F-38044 Grenoble, France

来源：

BIOCHEMICAL PHARMACOLOGY | 2016年 / 106卷

关键词：

Bromodomains; Acetylated histones; BET proteins; Epigenetic drugs; Drug discovery; SMALL-MOLECULE INHIBITORS; FRAGMENT-BASED DISCOVERY; TRANSCRIPTIONAL ACTIVITY; CBP/P300; BROMODOMAIN; SELECTIVE-INHIBITION; SYNERGISTIC ACTIVITY; DISPLACEMENT ASSAYS; EPIGENETIC READERS; DRUG DISCOVERY; CHEMICAL PROBE;

D O I：

10.1016/j.bcp.2015.12.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Bromodomains are epigenetic readers of histone acetylation involved in chromatin remodeling and transcriptional regulation. The human proteome comprises 46 bromodomain-containing proteins with a total of 61 bromodomains, which, despite highly conserved structural features, recognize a wide array of natural peptide ligands. Over the past five years, bromodomains have attracted great interest as promising new epigenetic targets for diverse human diseases, including inflammation, cancer, and cardiovascular disease. The demonstration in 2010 that two small molecule compounds, JQ1 and I-BET762, potently inhibit proteins of the bromodomain and extra-terminal (BET) family with translational potential for cancer and inflammatory disease sparked intense efforts in academia and pharmaceutical industry to develop novel bromodomain antagonists for therapeutic applications. Several BET inhibitors are already in clinical trials for hematological malignancies, solid tumors and cardiovascular disease. Currently, the field faces the challenge of single-target selectivity, especially within the BET family, and of overcoming problems related to the development of drug resistance. At the same time, new trends in bromodomain inhibitor research are emerging, including an increased interest in non-BET bromodomains and a focus on drug synergy with established antitumor agents to improve chemotherapeutic efficacy. This review presents an updated view of the structure and function of bromodomains, traces the development of bromodomain inhibitors and their potential therapeutic applications, and surveys the current challenges and future directions of this vibrant new field in drug discovery. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：1 / 18

页数：18

共 169 条

[21] Inhibition of bromodomain and extraterminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence [J].

Chaidos, Aristeidis ;

Caputo, Valentina ;

Karadimitris, Anastasios .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (03) :128-141

[22] BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536 [J].

Chen, Lijia ;

Yap, Jeremy L. ;

Yoshioka, Makoto ;

Lanning, Maryanna E. ;

Fountain, Rachel N. ;

Raje, Mithun ;

Scheenstra, Jacob A. ;

Strovel, Jeffrey W. ;

Fletcher, Steven .

ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07) :764-769

[23]

Chen P., 2015, J Med Chem

[24] Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions [J].

Choudhary, Chunaram ;

Kumar, Chanchal ;

Gnad, Florian ;

Nielsen, Michael L. ;

Rehman, Michael ;

Walther, Tobias C. ;

Olsen, Jesper V. ;

Mann, Matthias .

SCIENCE, 2009, 325 (5942) :834-840

[25] Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery [J].

Chung, Chun-wa ;

Dean, Anthony W. ;

Woolven, James M. ;

Bamborough, Paul .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) :576-586

[26] Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains [J].

Chung, Chun-wa ;

Coste, Herve ;

White, Julia H. ;

Mirguet, Olivier ;

Wilde, Jonathan ;

Gosmini, Romain L. ;

Delves, Chris ;

Magny, Sylvie M. ;

Woodward, Robert ;

Hughes, Stephen A. ;

Boursier, Eric V. ;

Flynn, Helen ;

Bouillot, Anne M. ;

Bamborough, Paul ;

Brusq, Jean-Marie G. ;

Gellibert, Francoise J. ;

Jones, Emma J. ;

Riou, Alizon M. ;

Homes, Paul ;

Martin, Sandrine L. ;

Uings, Iain J. ;

Toum, Jerome ;

Clement, Catherine A. ;

Boullay, Anne-Benedicte ;

Grimley, Rachel L. ;

Blande, Florence M. ;

Prinjha, Rab K. ;

Lee, Kevin ;

Kirilovsky, Jorge ;

Nicodeme, Edwige .

JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (11) :3827-3838

[27] Dual kinase-bromodomain inhibitors for rationally designed polypharmacology [J].

Ciceri, Pietro ;

Mueller, Susanne ;

O'Mahony, Alison ;

Fedorov, Oleg ;

Filippakopoulos, Panagis ;

Hunt, Jeremy P. ;

Lasater, Elisabeth A. ;

Pallares, Gabriel ;

Picaud, Sarah ;

Wells, Christopher ;

Martin, Sarah ;

Wodicka, Lisa M. ;

Shah, Neil P. ;

Treiber, Daniel K. ;

Knapp, Stefan .

NATURE CHEMICAL BIOLOGY, 2014, 10 (04) :305-+

[28] LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor [J].

Clark, Peter G. K. ;

Vieira, Lucas C. C. ;

Tallant, Cynthia ;

Fedorov, Oleg ;

Singleton, Dean C. ;

Rogers, Catherine M. ;

Monteiro, Octovia P. ;

Bennett, James M. ;

Baronio, Roberta ;

Mueller, Susanne ;

Daniels, Danette L. ;

Mendez, Jacqui ;

Knapp, Stefan ;

Brennan, Paul E. ;

Dixon, Darren J. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (21) :6217-6221

[29] Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing [J].

Cleary, Sean P. ;

Jeck, William R. ;

Zhao, Xiaobei ;

Chen, Kui ;

Selitsky, Sara R. ;

Savich, Gleb L. ;

Tan, Ting-Xu ;

Wu, Michael C. ;

Getz, Gad ;

Lawrence, Michael S. ;

Parker, Joel S. ;

Li, Jinyu ;

Powers, Scott ;

Kim, Hyeja ;

Fischer, Sandra ;

Guindi, Maha ;

Ghanekar, Anand ;

Chiang, Derek Y. .

HEPATOLOGY, 2013, 58 (05) :1693-1702

[30] BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells [J].

Coude, Marie-Magdelaine ;

Braun, Thorsten ;

Berrou, Jeannig ;

Dupont, Melanie ;

Bertrand, Sibyl ;

Masse, Aline ;

Raffoux, Emmanuel ;

Itzykson, Raphael ;

Delord, Marc ;

Riveiro, Maria E. ;

Herait, Patrice ;

Baruchel, Andre ;

Dombret, Herve ;

Gardin, Claude .

ONCOTARGET, 2015, 6 (19) :17698-17712

← 1 2 3 4 5 6 7 8 9 10 →